1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Thymus Neoplasms in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Thymus Neoplasms: Tumors or cancer of the THYMUS GLAND.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dornand, J | 1 |
Bouaboula, M | 1 |
d'Angeac, AD | 1 |
Favero, J | 1 |
Shire, D | 1 |
Casellas, P | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Thymus Neoplasms
Article | Year |
---|---|
Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Base Sequence; Cell Line; Dose-Re | 1992 |